Endothelin contributes to the hemodynamic effects of vasopressin in spontaneous hypertension.

European Journal of Pharmacology

Volumn 334, Issue 1, 1997, Pages 55-60

  Balakrishnan, Suchitra M ^a   Gopalakrishnan, Venkat ^a   McNeill, J Robert ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Cardiac output; Endothelin; Hemodynamics; Radiotelemetry; Spontaneously hypertensive rats (SHR); Vasopressin

Indexed keywords

ARGIPRESSIN; BOSENTAN; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HEART OUTPUT; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIAC OUTPUT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; HEART RATE; HEMODYNAMIC PROCESSES; HYPERTENSION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SULFONAMIDES; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 0030766312     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01131-X     Document Type: Article

References (12)

1. Bakris G.L., Fairbanks R., Traish A.M., Akerstrom V., Kern S. Arginine, vasopressin stimulates human mesangial cell production of endothelin. J. Clin. Invest. 87:1991;1158-1164.
2. Balakrishnan S., Gopalakrishnan V., Wilson T.W., McNeill J.R. Effect of an endothelin antagonist on hemodynamic responses to angiotensin II. Hypertension. 28:1996;806-809.
3. Batra V.K., McNeill J.R., Xu Y., Wilson T.W., Gopalakrishnan V. ETB receptors on aortic smooth muscle cells of spontaneously hypertensive rats. Am. J. Physiol. 264:1993;C479-C484.
4. Chen L., McNeill J.R., Wilson T.W., Gopalakrishnan V. Differential effects of phosphoramidon on contractile responses to angiotensin II in rat blood vessels. Br. J. Pharmacol. 114:1995;1599-1604.
5. Chen L., McNeill J.R., Wilson T.W., Gopalakrishnan V. Heterogeneity in vascular smooth muscle responsiveness to angiotensin II: Role of endothelin. Hypertension. 26:1995;83-88.
6. Clozel M., Breu V., Gray G.A., Kalina B., Loffler B.-M., Burri K., Cassal J.-M., Hirth G., Muller M., Neidhart W., Ramuz H. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther. 270:1994;228-235.
7. Datar S., Chiu E.K.Y., McNeill J.R. Reflexes fail to reduce pressor activity of vasopressin in spontaneous hypertension. Am. J. Physiol. 248:1985;H49-H54.
8. Emmeluth C., Bie P. Effects, release and disposal of endothelin 1 in conscious dogs. Acta Physiol. Scand. 146:1992;197-204.
9. Emori T., Hirata Y., Ohta K., Kanno K., Eguchi S., Imai T., Shichiri M., Marumo F. Cellular mechanism of endothelin-1 release by angiotensin and vasopressin. Hypertension. 18:1991;165-170.
10. Imai T., Hirata Y., Emori T., Yanagisawa M., Masaki T., Marumo F. Induction of endothelin- 1 gene by angiotensin and vasopressin in endothelial cells. Hypertension. 19:1992;753-757.
11. Mohring J., Kintz J., Schoun J., McNeill J.R. Pressor responsiveness and cardiovascular reflex activity in spontaneously hypertensive and normotensive rats during vasopressin infusion. J. Cardiovasc. Pharmacol. 3:1981;948-957.
12. Tomobe Y., Yanagisawa M., Fujimori A., Masaki T., Goto K. Argininevasopressin increases the release of ET-1 into perfusate of rat mesenteric artery. Biochem. Biophys. Res. Commun. 191:1993;654-661.